Forman H J, Zhou H, Gozal E, Torres M
Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles 90033, USA.
Environ Health Perspect. 1998 Oct;106 Suppl 5(Suppl 5):1185-90. doi: 10.1289/ehp.98106s51185.
Stimulation of alveolar macrophages (AM) with adenosine-5-diphosphate (ADP) results in transient production of superoxide anion radical (O2.-; superoxide) and H2O2 in a metabolic event known as the respiratory burst. Initiation of the respiratory burst appears to depend on activation of protein kinase activity, whereas protein phosphatases might involved in termination of the burst. The involvement of protein kinase C was suggested by inhibition by bisindolylmaleimide I (GF 109203X), a relatively specific inhibitor. KN-62, an inhibitor of calcium-calmodulin protein kinase II, also partly inhibited the respiratory burst stimulated by ADP and phorbol esters. The role of protein phosphatases in termination of the ADP-stimulated respiratory burst of AM was examined with calyculin A (CA) (25-75 nM) or okadaic acid (OA) (1-5 microM), two inhibitors of protein phosphatase 1 and 2a (PP1;PP2a). A dose-dependent prolongation of the respiratory burst was observed in the presence of these inhibitors. CA and OA also markedly enhanced the rate of superoxide production stimulated by ADP, consistent with involvement of PP1/PP2a in regulating both the rate of activation and timing of termination. Treatment of AM with cyclosporin A (CsA) (1-50 microM), an inhibitor of the calcium-dependent protein phosphatase 2b (PP2b), stimulated superoxide production by itself and significantly prolonged the duration of ADP-stimulated superoxide production. CsA, however, did not increase the ADP-stimulated rate of superoxide production. Thus, PP1/PP2a appear to be the primary phosphatases for controlling the intensity of the respiratory burst during receptor-elicited superoxide production in AM, whereas PP1/PP2a and PP2b play a role in turning off the respiratory burst.
用二磷酸腺苷(ADP)刺激肺泡巨噬细胞(AM)会导致超氧阴离子自由基(O2.-;超氧物)和H2O2在一种被称为呼吸爆发的代谢事件中短暂产生。呼吸爆发的启动似乎依赖于蛋白激酶活性的激活,而蛋白磷酸酶可能参与爆发的终止。双吲哚马来酰亚胺I(GF 109203X)是一种相对特异的抑制剂,其抑制作用提示了蛋白激酶C的参与。KN-62是钙调蛋白依赖性蛋白激酶II的抑制剂,它也部分抑制了ADP和佛波酯刺激的呼吸爆发。用两种蛋白磷酸酶1和2a(PP1;PP2a)的抑制剂,即花萼海绵诱癌素A(CA)(25 - 75 nM)或冈田酸(OA)(1 - 5 microM),研究了蛋白磷酸酶在终止AM的ADP刺激的呼吸爆发中的作用。在这些抑制剂存在的情况下,观察到呼吸爆发呈剂量依赖性延长。CA和OA还显著提高了ADP刺激的超氧物产生速率,这与PP1/PP2a参与调节激活速率和终止时间一致。用钙依赖性蛋白磷酸酶2b(PP2b)的抑制剂环孢素A(CsA)(1 - 50 microM)处理AM,其自身刺激了超氧物的产生,并显著延长了ADP刺激的超氧物产生的持续时间。然而,CsA并没有增加ADP刺激的超氧物产生速率。因此,PP1/PP2a似乎是控制AM在受体引发的超氧物产生过程中呼吸爆发强度的主要磷酸酶,而PP1/PP2a和PP2b在关闭呼吸爆发中发挥作用。